Peer review Peer review information Nature Communications thanks Gordana Wozniak-Knopp and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
At the time, CMS Administrator Mehmet Oz said BALANCE would "expand access and lower prices for obesity GLP-1 medications without passing the bill to taxpayers." CMS said the Medicaid portion of the BALANCE program will continue with applications open to states through July 31
Women gain an average of 1.5 pounds per year during midlife, accumulating roughly 12 pounds within eight years of menopause
multiple units can be billed when more time is spent
While the move does not mean the compounds would necessarily become FDA-approved drugs, it would allow them to be prescribed and compounded in a regulated medical setting rather than being pushed into an unregulated, potentially shadowy marketplace
Full report: 436 Comments Pharmacy Times 102K followers New hypertension guidelines are here
